ABBV - AbbVie - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ABBV is currently covered by 23 analysts with an average price target of $213.79. This is a potential upside of $27.4 (14.7%) from yesterday's end of day stock price of $186.39.

AbbVie's activity chart (see below) currently has 411 price targets and 356 ratings on display. The stock rating distribution of ABBV is 84.52% BUY and 15.48% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 92.44% with an average time for these price targets to be met of 485.82 days.

Highest price target for ABBV is $250, Lowest price target is $181, average price target is $208.48.

Most recent stock forecast was given by GEOFF MEACHAM from CITI on 13-May-2025.

Currently out of the existing stock ratings of ABBV, 71 are a BUY (84.52%), 13 are a HOLD (15.48%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$205

$12.55 (6.52%)

$215

2 months 2 days ago
(13-May-2025)

12/14 (85.71%)

$27.59 (15.55%)

285

Buy

$216

$23.55 (12.24%)

$214

2 months 17 days ago
(28-Apr-2025)

23/26 (88.46%)

$22.49 (11.62%)

431

Buy

$250

$57.55 (29.90%)

$241

2 months 18 days ago
(27-Apr-2025)

12/18 (66.67%)

$57.66 (29.98%)

526

Buy

$240

$47.55 (24.71%)

$210

4 months 11 days ago
(04-Mar-2025)

7/8 (87.5%)

$28.46 (13.45%)

474

Hold

$223

$30.55 (15.87%)

$191

4 months 12 days ago
(03-Mar-2025)

3/4 (75%)

$15.71 (7.58%)

443

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ABBV (AbbVie) average time for price targets to be met?

On average it took 485.82 days on average for the stock forecasts to be realized with a an average price target met ratio 92.44

Which analyst has the current highest performing score on ABBV (AbbVie) with a proven track record?

JOHN BORIS

Which analyst has the most public recommendations on ABBV (AbbVie)?

John Boris has 1 price targets and 1 ratings on ABBV

Which analyst is the currently most bullish on ABBV (AbbVie)?

Terence Flynn with highest potential upside - $57.55

Which analyst is the currently most reserved on ABBV (AbbVie)?

Alex Arfaei with lowest potential downside - -$113.45

AbbVie in the News

HSBC upgrades Divi's Laboratories stock rating to Buy on growth potential

Investing.com – HSBC has upgraded Divi’s Laboratories Ltd (NS:DIVI) from Reduce to Buy, while significantly raising its price target to INR7,900.00 from INR5,020.00. The upgrade reflects HSBC’s more constructive view of growth potential for Divi’s custom synthesis segment, particularly noting the company’s role as a global supplier of peptide fragments used in Eli Lilly (NYSE:LLY)’s...

Prime Medicine stock soars amid gene editing sector momentum

Investing.com — Prime Medicine (NASDAQ:PRME) stock rose 32%, extending recent gains following Eli Lilly’s (NYSE:LLY) acquisition deal for Verve Therapeutics (NASDAQ:VERV) last month. The gene editing company has seen its shares surge approximately 160% since mid-June, building on momentum that began after a management change on May 19. The rally comes as investors reassess valuations...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?